The efficacy and safety of patent Foramen Ovale Closure for Refractory Epilepsy (PFOC-RE): a prospectively randomized control trial of an innovative surgical therapy for refractory epilepsy patients with PFO of high-grade right-to-left shunt.

MLA

Shuming, Ji, et al. “The Efficacy and Safety of Patent Foramen Ovale Closure for Refractory Epilepsy (PFOC-RE): A Prospectively Randomized Control Trial of an Innovative Surgical Therapy for Refractory Epilepsy Patients with PFO of High-Grade Right-to-Left Shunt.” BMC Neurology, vol. 23, no. 1, July 2023, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s12883-023-03317-0.

APA

Shuming, J., Hua, L., Yusha, T., & Lei, C. (2023). The efficacy and safety of patent Foramen Ovale Closure for Refractory Epilepsy (PFOC-RE): a prospectively randomized control trial of an innovative surgical therapy for refractory epilepsy patients with PFO of high-grade right-to-left shunt. BMC Neurology, 23(1), 1–11. https://doi.org/10.1186/s12883-023-03317-0

Chicago

Shuming, Ji, Li Hua, Tang Yusha, and Chen Lei. 2023. “The Efficacy and Safety of Patent Foramen Ovale Closure for Refractory Epilepsy (PFOC-RE): A Prospectively Randomized Control Trial of an Innovative Surgical Therapy for Refractory Epilepsy Patients with PFO of High-Grade Right-to-Left Shunt.” BMC Neurology 23 (1): 1–11. doi:10.1186/s12883-023-03317-0.